Viewing Study NCT06332092


Ignite Creation Date: 2025-12-24 @ 3:43 PM
Ignite Modification Date: 2026-02-20 @ 8:07 PM
Study NCT ID: NCT06332092
Status: RECRUITING
Last Update Posted: 2025-08-28
First Post: 2024-03-12
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: FID-007 and Cetuximab in Treating Patients With Advanced Head and Neck Squamous Cell Carcinoma
Sponsor: Fulgent Pharma LLC.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module